SimBioSys is a series a startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
SimBioSys has developed a software platform, TumorScope, that creates 3D virtual models of a patient's tumor to simulate and predict its response to various cancer therapies, enabling precision medicine.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky